-
1
-
-
18744369886
-
Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis
-
Ramoz N, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32:579
-
(2002)
Nat Genet
, vol.32
, pp. 579
-
-
Ramoz, N.1
-
2
-
-
0037813131
-
Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents
-
Antonsson A, et al. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 2003; 84:1881
-
(2003)
J Gen Virol
, vol.84
, pp. 1881
-
-
Antonsson, A.1
-
3
-
-
0036208342
-
Human papillomaviruses and non-melanoma skin cancer
-
Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002; 15:101
-
(2002)
Curr Opin Infect Dis
, vol.15
, pp. 101
-
-
Harwood, C.A.1
Proby, C.M.2
-
4
-
-
0038267379
-
Clinical aspects of epidermodysplasia verruciformis
-
de Oliveira WRP, et al. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2003; 17:394
-
(2003)
J Eur Acad Dermatol Venereol
, vol.17
, pp. 394
-
-
de Oliveira, W.R.P.1
-
5
-
-
33748890926
-
Skin cancer in epidermodysplasia verruciformis patients from Brazil
-
de Oliveira WRP, et al. Skin cancer in epidermodysplasia verruciformis patients from Brazil. J Eur Acad Dermatol Venereol 2006; 20:1133
-
(2006)
J Eur Acad Dermatol Venereol
, vol.20
, pp. 1133
-
-
de Oliveira, W.R.P.1
-
6
-
-
0002722917
-
Epidermodysplasia verruciformis
-
Friedman RJ, et al, eds, Philadelphia: W.B. Saunders
-
Jablonska S. Epidermodysplasia verruciformis. In: Friedman RJ, et al, eds. Cancer of the Skin. Philadelphia: W.B. Saunders,1991: 101
-
(1991)
Cancer of the Skin
, pp. 101
-
-
Jablonska, S.1
-
7
-
-
0030892955
-
A novel human papillomavirus identified in epidermodysplasia verruciformis
-
Harris AJ, et al. A novel human papillomavirus identified in epidermodysplasia verruciformis. Br J Dermatol 1997: 136:587
-
(1997)
Br J Dermatol
, vol.136
, pp. 587
-
-
Harris, A.J.1
-
8
-
-
12944332999
-
UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes
-
Akgul B, et al. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch Virol 2005; 150:145
-
(2005)
Arch Virol
, vol.150
, pp. 145
-
-
Akgul, B.1
-
9
-
-
2942588878
-
Sunlight exposure and (sero) prevalence of epidermodysplasia verruciformis-associated human papillomavirus
-
Termorshuizen F, et al. Sunlight exposure and (sero) prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol 2004; 122:1456
-
(2004)
J Invest Dermatol
, vol.122
, pp. 1456
-
-
Termorshuizen, F.1
-
10
-
-
0034778324
-
Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis
-
Padlewska K, et al. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J Invest Dermatol 2001; 117:935
-
(2001)
J Invest Dermatol
, vol.117
, pp. 935
-
-
Padlewska, K.1
-
11
-
-
0035433882
-
Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a
-
Anadolu R, et al. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. J Am Acad Dermatol 2001; 45:296
-
(2001)
J Am Acad Dermatol
, vol.45
, pp. 296
-
-
Anadolu, R.1
-
12
-
-
0032965876
-
Epidermodysplasia verruciformis treated using topical 5-aminolevulinic acid photodynamic therapy
-
Karrer S, et al. Epidermodysplasia verruciformis treated using topical 5-aminolevulinic acid photodynamic therapy. Br J Dermatol 1999; 140:935
-
(1999)
Br J Dermatol
, vol.140
, pp. 935
-
-
Karrer, S.1
|